Biotechnology News

May 2, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus advancing Z160, in multiple chronic pain clinical trials. Formulation selected - will initiate two Phase 2a clinical trials; the first to begin enrolling in the third quarter of 2012.

May 2, 2012

AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics announces publication of new results in the journal Leukemia demonstrating therapeutic delivery of microRNA-34 mimics

May 2, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the Company's presentations at two upcoming investment conferences. Illumina will webcast its presentation at the Robert W. Baird Growth Stock...

May 2, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Pharmaceuticals Inc. (NASDAQ: AVEO) announced today preliminary data from the exploratory, randomized Phase 2 study comparing the combination of ficlatuzumab and gefitinib, an EGFR tyrosine kinase inhibitor...

May 2, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: DiaGenic (OSE:DIAG) Presentation of results for first quarter 2012 will take place 09:00 (Norwegian time), Wednesday 9 May at Felix Conference Centre, Bryggetorget 3, Aker brygge in Oslo. The...

May 2, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Target Amarantus BioSciences Reports Positive Pre-Clinical Results of Parkinson’s Treatment

May 2, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Avedro accelerated cross-linking science to be featured at ARVO.

May 1, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the Deutsche Bank 37th Annual Health Care Conference. The live presentation will occur...

May 1, 2012

NEW YORK & CARMIEL, Israel--(BUSINESS WIRE)--Pfizer Inc.(NYSE:PFE) and Protalix BioTherapeutics, Inc. (NYSE-AMEX:PLX, TASE:PLX) announced today that the United States (U.S.) Food and Drug Administration (FDA) approved ELELYSO™ (taliglucerase...

May 1, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the first patient has been dosed in a Phase 3 clinical trial evaluating the efficacy and safety of GS-1101 (formerly CAL-101). GS-1101 is an...

May 1, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) announced today that David Perry, the company’s Chief Executive Officer, will provide a company overview at the Deutsche Bank Annual Health Care Conference on Monday May 7,...

May 1, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Deutsche Bank 37th Annual Health Care Conference in Boston. John F. Milligan, PhD, Gilead’s...

May 1, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) announced today it will present at the Bank of America Merrill Lynch 2012 Health Care Conference on Tuesday, May 15, 2012 at 11:20 a.m. (PT) / 2:20 p.m. (ET) in Las Vegas. The...

May 1, 2012

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today revenue of $58.6 million for the first...

May 1, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a specialty pharmaceutical company focused on the development and commercialization of Feraheme® (ferumoxytol) Injection for intravenous (IV) use to treat iron...

May 1, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (OTCBB:INSV) today reported financial results for the quarter ended March 31, 2012. Total revenues for the first quarter of 2012 were $2.3 million, a decrease of $0.8 million from the...

May 1, 2012

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ: CERS) announces financial results for the first quarter ended March 31, 2012.

May 1, 2012

ARLINGTON, Tenn.--(BUSINESS WIRE)--Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company and a leading provider of surgical solutions for the foot and ankle market, today reported financial results for its first...

May 1, 2012

DUBLIN--(BUSINESS WIRE)--Covidien plc (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced that it has completed the previously announced...

May 1, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Harry Glorikian, Managing Partner, Scientia Advisors, delivers the keynote to the business leaders of the Boston life science community at the groundbreaking ceremony of Sony DADC in Cambridge, MA.

May 1, 2012

WASHINGTON--(BUSINESS WIRE)--Mark J. Riedy, a Member of the Corporate & Securities Section and Energy & Clean Technology Practice at Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., will give a plenary address at the World Congress on...

May 1, 2012

SAN FRANCISCO--(BUSINESS WIRE)--ClinStar to Present at Outsourcing Clinical Trials Europe on Successfully Conducting Clinical Trials in Russia and parts of Eastern Europe.

May 1, 2012

MADISON, Wis.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific Nicolet iS50 FT-IR spectrometer, the first research-grade FT-IR with one-touch operation. Building on the...

May 1, 2012

WASHINGTON--(BUSINESS WIRE)--The 2012 BIO International Convention looks to give a global perspective on regulatory and acceptance issues within the food and agriculture sector of the biotechnology industry.

May 1, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes reported today that in separate interviews Chief Executive Officer,...

May 1, 2012

CHAMPAIGN, Ill.--(BUSINESS WIRE)--ImmuVen was awarded a $1.68 million Phase II Small Business Innovation Research (SBIR) grant, allowing it to continue to develop its biotherapeutic targeting highly antibiotic resistant organisms.

May 1, 2012

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (OTCBB: TBIO) today announced the following Webcast:     What: Transgenomic, Inc. First Quarter 2012 Financial Results and Business Update Conference Call   When: Tuesday, May 8, 2012 @ 5:00 p.m....

May 1, 2012

SILVER SPRING, Md.--(BUSINESS WIRE)--Nuvilex, Inc.(OTCQB:NVLX) announced the Dawson James Financial Services consulting agreement, a key driver toward closing the SG Austria asset acquisition.

May 1, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme announced participation in Deloitte Recap's Allicense, Licensing Executive Society's Spring Meeting and the Epigenetics in Drug Discovery Conference at the Omics Evolution Summit, with others.

May 1, 2012

AUSTIN, Texas--(BUSINESS WIRE)--Clinical utility of Asuragen's miRInform® Thyroid cancer Panel used in conjunction with Ultrasound-Guided Fine Needle Aspiration

May 1, 2012

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Lupin purchases Provantis from Instem

May 1, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. gastroenterologists and managed care organization (MCO) pharmacy...

May 1, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has acquired Doe & Ingalls Management, LLC, a premium provider of specialty production chemicals and...

May 1, 2012

NEWTON, Mass.--(BUSINESS WIRE)--Galectin Therapeutics signs long-term agreement with Scott Friedman, MD, a renowned physician and researcher in liver disease.

May 1, 2012

MADISON, Wis.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific Nicolet iS50 FT-IR spectrometer, the first research-grade FT-IR with one-touch operation. Building on the...

May 1, 2012

SALT LAKE CITY--(BUSINESS WIRE)--Great Basin Corporation, a privately-held life sciences company developing sample-to-result molecular diagnostic solutions, today announced that the FDA approved its c.diff assay

May 1, 2012

MALVERN, Pa.--(BUSINESS WIRE)--Promedior announced that data from preclinical studies of recombinant human Pentraxin-2 (rPTX-2) will be presented at the Annual Meeting of the Association for Research in Vision and Ophthalmology.

May 1, 2012

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced...

May 1, 2012

ARLINGTON, Va. & DEERFIELD, Ill.--(BUSINESS WIRE)--Mark V. Pauly, Ph.D., has been named the 2012 recipient of the William B. Graham Prize for Health Services Research. The Prize, funded by The Baxter International Foundation and managed by...

May 1, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE AMEX: SNT) announced today that a high level of tumor eradication in a mouse model of human multiple myeloma was achieved with a combination of...

May 1, 2012

STRONGSVILLE, Ohio--(BUSINESS WIRE)--Sparton Corporation (NYSE:SPA) announces that Sparton Medical’s collaborative design and engineering work with HS Design in Gladstone, NJ has helped BioMarker Strategies become a finalist for a 2012 Medical...

May 1, 2012

BENSALEM, Pa.--(BUSINESS WIRE)--A recent survey of 140 Lupin Pharmaceuticals, Inc., field sales reps and district managers assessing the impact of BusinessOne Technologies, Inc.’s Maestro Lite analytics solution found that increased knowledge of...

May 1, 2012

PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Pall Corporation will introduce five new single-use products designed to improve bioprocessing efficiency at INTERPHEX 2012, which starts today at the Jacob Javits Center in New York City booth #3021

May 1, 2012

DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the Deutsche...

May 1, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Novella Clinical, a full service clinical research organization, today announced Kevin B. Johnson, Ph.D., has joined as global head regulatory affairs.

May 1, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Tuesday, May 8, 2012, at 4:30 p.m. ET. During the call, management will provide an update on Infinity’s business and discuss the...

May 1, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis to present abstract at American Association of Immunologists